Not with easier lab workflows, but by removing the cleanroom requirement. EVEA™ uses your existing operating theatre, andrology lab and embryology staff — removing only the cleanroom, incubator bank and HEPA filtration that make full IVF impossible for secondary-city hospitals.
Eve provides the device, training, and protocols. You provide the clinic and the patients. We earn as you grow — per-cycle, recurring. No upfront build. No lab infrastructure. Just a medical device and a playbook. The entire model is built around partner success and clinical access.
Single-use, pre-loaded device. Clinical protocols. Staff training. Regulatory scaffolding. Everything you need to launch IVC.
Eve earns a platform fee per IVC cycle. As you run more cycles, we grow. Incentives perfectly aligned with your clinical success.
We don't operate your clinic. One playbook, deployed site by site across Asia-Pacific. Hospital-owned, Eve-enabled.
Eve is led by a team combining deep MedTech commercial experience with clinical and regulatory expertise — Founder & CEO Yve Lyppens and Co-Founder & Director of Medical Affairs Col. Dr. Othman Sukhilmi.
Meet the team →Eve Fertility Ltd. is incorporated in Hong Kong SAR, with an active deployment pipeline across Asia-Pacific — the secondary-city hospital systems where fertility infrastructure does not yet exist.
For hospital systems, fertility operators, investors, regulators and partners across Asia-Pacific.
Request a briefing → Explore EVEA™